Integration of Palliative Care in Pediatric Onco-hematology

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorNantes University Hospital

About this trial

PALONCOPED is a multicentre, interregional, observational and qualitative study aiming to better understand the early integration of palliative care in children with cancer. This study compares the practices, representations and temporalities of integration according to the type of cancer, in particular between hematological malignancies and solid tumors. The study seeks to identify the obstacles and levers encountered by professionals in pediatric onco-haematology and pediatric palliative care resource teams. It will be conducted in the hospitals of Nantes, Angers and Tours, based on about 45 semi-structured individual interviews with healthcare professionals. The data will be analyzed according to a reflexive thematic analysis, supplemented if relevant by a lexical analysis. The project aims to identify ways to improve for organizational and relational improvement, to strengthen collaboration between teams, and to promote earlier, coordinated care pathways adapted to children and their families.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Healthcare professional (doctor with a thesis that has validated his DES, qualified nurse or puériculturist, qualified childcare assistant or nursing assistant, qualified psychologist, qualified physiotherapist/occupational therapist) practicing in pediatric onco-hematology or within the Pediatric Palliative Support Care Team of three university hospital centers: Nantes, Angers, and Tours., with regular exercise for at least 3 months.

Having been involved in supporting a child in a palliative situation in the last 9 months.

Agreement of professionals to participate in the study, to record and transcribe interviews.

Disqualifiers

None

Trial population

We will focus on health professionals working in pediatric onco-hematology services and within the Pediatric Palliative Support Care Team. Participation in the study will be offered to professionals from targeted services by the research team directly in the services via both information by email, a poster in the break rooms and a project presentation meeting.

Trial design

Design model

Other

Time perspective

Prospective

Treatments tested in this trial

  • PALONCOPED semi-structured interview

    Other intervention

    Only one semi-structured interview will be conducted per participant. It is estimated that the average duration of interviews is 45 minutes (given for information purposes to allow participants to anticipate the time needed for this interview). Individual interviews will be conducted by 1 researcher in Psychology. The researcher is trained in qualitative medicine and semi-structured interviews. He has extensive experience in this field.

Treatment groups

45 Participants
are divided into 1 treatment group
Group A: PALONCOPED Study population1 intervention

Trial outcomes

Primary outcomes

1

Identify the barriers and levers for the early integration of palliative care into pediatric oncology-hematology care, depending on the type of pathology (malignant blood diseases versus so-lide tumors)

Time frame
Inclusion (Day 0)

Secondary outcomes

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Nantes University Hospital

Lead sponsor

Association CASSANDRA

Collaborator

This trial is not recruiting at the moment. You can still explore other options: